Acambis ousts CEO and Financial Director
The vaccine maker Acambis ousted their CEO and a financial director after they failed to get a $1 billion smallpox contract with the US government.
Acambis ousts CEO and finance director
Stockholder had wanted a change in direction and it looks like they will now get it. Acambis had been concentrating on vaccines related to bio-defense.
The new CEO is Ian Garland who was head of Arrow Therapeutics when the deal was put together to be acquired by AstraZeneca. This has fueled rumors that Acambis may try to put itself on the market.
It is likely not the last of layoffs as the company has stated they will shed 20% of their workforce which amounts to about 40 jobs. It will be interesting to keep an eye on what happens to them in the next couple of years.
Technorati Tags: Acambis, down-sizing, layoffs
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
